```html

Quinine Fever (Quinism) – A Complete Patient Guide

Overview

Quinine fever, also called quinism or quinine toxicity, is a systemic reaction that occurs after ingestion of excessive amounts of quinine or related compounds. Quinine is a bitter alkaloid historically used to treat malaria and is still found in prescription “sarch‑gran” tablets, some over‑the‑counter (OTC) tonic waters, and herbal supplements marketed for muscle cramps.

Most cases are drug‑induced; true “fever” (elevated body temperature) is uncommon, but patients often experience flu‑like symptoms that mimic an infection, hence the name.

• Who it affects: Adults who consume high‑dose quinine for malaria prophylaxis, menstrual‑related cramps, or as a “natural remedy.” Elderly patients and those with kidney or liver disease are especially vulnerable.
• Prevalence: In the United States, quinine‑related adverse events are reported to the FDA’s MedWatch system at a rate of roughly 2–4 cases per 100,000 prescriptions per year. Worldwide, the exact incidence is unknown because quinine is used less frequently outside malaria‑endemic zones.

Because quinine is now regulated (prescription‑only in the U.S.) and tonic water contains only <10 mg per 8‑oz serving (well below toxic levels), quinine fever is relatively rare. However, misuse of OTC “cramp relief” tablets (often containing 200–300 mg quinine per tablet) can quickly lead to toxicity.

Symptoms

Symptoms usually appear 30 minutes to 12 hours after ingestion and may range from mild to life‑threatening. The presentation can be divided into systemic and organ‑specific effects.

Systemic (General) Symptoms

• Fever or chills – Often low‑grade (≤38.5 °C) but can be higher.
• Headache – Ranges from dull ache to severe migraine‑like pain.
• Myalgia & arthralgia – Muscle and joint aches resembling flu.
• Fatigue & weakness – Patients may feel unable to stand or walk.
• Acute dizziness or vertigo – Related to blood‑pressure changes.
• Nausea, vomiting, and abdominal cramps – Gastrointestinal upset is very common.
• Diarrhea – Occasionally bloody if intestinal mucosa is damaged.

Cardiovascular & Respiratory Symptoms

• Hypotension – Low blood pressure caused by vasodilation.
• Arrhythmias – Premature ventricular contractions, atrial fibrillation, or torsades de pointes in severe cases.
• Shortness of breath – May be due to pulmonary edema or cardiac involvement.

Neurologic Symptoms (Quinine‑Induced Neurotoxicity)

• Tinnitus – Ringing in the ears, often the first sign.
• Hearing loss – Can be reversible if recognized early, but may become permanent.
• Visual disturbances – Blurred vision or transient blindness.
• Peripheral neuropathy – Tingling, numbness, or burning sensations in the hands/feet.
• Seizures – Rare but possible in high‑dose exposure.

Hematologic & Dermatologic Symptoms

• Thrombocytopenia – Low platelet count leading to easy bruising.
• Hemolytic anemia – Particularly in patients with G6PD deficiency.
• Skin rash – Maculopapular or urticarial eruptions.
• Pruritus – Itching without a visible rash.

Causes and Risk Factors

Quinine fever is essentially an overdose or hypersensitivity reaction to quinine. The mechanisms include:

• Direct toxic effect on cardiac myocytes, the central nervous system, and the renal tubules.
• Immune‑mediated hypersensitivity (type I or type II), leading to rash, fever, and hematologic abnormalities.

Common Sources of Quinine

1. Prescription antimalarial tablets (e.g., quinine sulfate 300 mg).
2. OTC “cramp” tablets – Each tablet may contain 200–300 mg quinine.
3. Tonic water – Up to 83 mg/L (≈10 mg per 8‑oz serving) – generally safe but can add to cumulative dose.
4. Herbal or “natural” supplements – Some contain unstandardized quinine extracts.

Risk Factors

• Taking quinine without a prescription or exceeding the recommended dose.
• Concurrent use of drugs that affect quinine metabolism (e.g., CYP3A4 inhibitors such as erythromycin, ketoconazole).
• Renal or hepatic impairment – reduces drug clearance.
• Pregnancy – quinine crosses the placenta and may affect the fetus.
• Genetic disorders: G6PD deficiency increases risk of hemolysis.
• Elderly patients – diminished physiologic reserve.

Diagnosis

Quinine fever is primarily a clinical diagnosis supported by laboratory testing. The key steps are:

History & Physical Examination

• Ask about recent quinine use (prescription, OTC, or tonic water).
• Identify timing of symptom onset relative to ingestion.
• Conduct a focused exam for fever, rash, neurologic deficits, cardiac rhythm, and signs of bleeding.

Laboratory Tests

• Serum quinine level – Measured by high‑performance liquid chromatography (HPLC); >10 µg/mL generally indicates toxicity.
• Complete blood count (CBC) – Look for thrombocytopenia, anemia, or leukopenia.
• Electrolytes & renal panel – Detect renal dysfunction or electrolyte disturbances.
• Liver function tests (LFTs) – Assess hepatic injury.
• Coagulation profile – PT/INR, aPTT if bleeding is suspected.
• Blood smear – To rule out malaria in patients taking quinine for prophylaxis.

Cardiac Monitoring

• 12‑lead ECG – Look for QT‑prolongation, arrhythmias, or conduction blocks.
• Continuous telemetry for patients with cardiac symptoms.

Neuro‑otologic Evaluation

• Audiometry if tinnitus or hearing loss is reported.
• Neurological exam for peripheral neuropathy or seizures.

Differential Diagnosis

Conditions that can mimic quinine fever include malaria, viral influenza, drug‑induced fever (e.g., from antibiotics), autoimmune vasculitis, and other toxic ingestions. Ruling these out helps confirm quinine as the culprit.

Treatment Options

Management focuses on supportive care, removal of the offending agent, and treating complications. There is no specific antidote for quinine.

Immediate Measures

1. Discontinue quinine intake immediately.
2. Assess airway, breathing, circulation (ABCs); provide supplemental oxygen if needed.
3. Establish IV access for fluid resuscitation.

Supportive Therapies

• Intravenous fluids – Normal saline or lactated Ringer’s to maintain blood pressure and renal perfusion.
• Inotropic agents (e.g., dopamine, norepinephrine) for refractory hypotension.
• Antiemetics – Ondansetron or metoclopramide for nausea/vomiting.
• Anticonvulsants – Lorazepam or levetiracetam if seizures occur.
• Anti‑arrhythmic therapy – Magnesium sulfate for torsades de pointes; amiodarone for other arrhythmias.

Specific Interventions

• Activated charcoal – If presentation is within 1–2 hours of ingestion and the airway is protected.
• Hemodialysis – Consider in severe renal failure, refractory hyperkalemia, or extremely high quinine levels (>20 µg/mL). Quinine is partially dialyzable.
• Corticosteroids – May be used for severe immune‑mediated reactions (e.g., rash, thrombocytopenia) after weighing risks.

Medication Adjustments

Review concurrent drugs that prolong QT interval (e.g., macrolides, fluoroquinolones) and hold them if possible.

Follow‑up Care

• Serial CBC and electrolytes every 12–24 hours until stable.
• Repeat ECG until QT interval normalizes.
• Audiology follow‑up for any hearing changes.

Living with Quinine Fever

Even after acute recovery, patients may need ongoing strategies to prevent recurrence and mitigate lingering effects.

Medication Review

• Never self‑medicate with quinine again; obtain a prescription only if absolutely necessary.
• Ask your pharmacist to flag quinine in your medication profile.

Monitoring for Late Effects

• Hearing: Schedule hearing tests 1–3 months post‑event if tinnitus or hearing loss occurred.
• Cardiac: Annual ECG if you experienced QT prolongation or arrhythmias.
• Blood counts: CBC check at 1 month and again at 3 months.

Lifestyle Adjustments

• Stay well‑hydrated to aid renal clearance.
• Limit alcohol intake – it can exacerbate liver toxicity.
• Maintain a balanced diet rich in potassium and magnesium, which help stabilize cardiac rhythm.
• Wear a medical alert bracelet stating “Quinine allergy / quinism” if you have had a severe reaction.

Psychosocial Support

Fever and systemic illness can be frightening. Seek counseling or support groups if anxiety about medication safety persists.

Prevention

Because quinine fever is largely preventable, the following steps are essential:

• Use quinine only under medical supervision. The FDA recommends quinine for malaria only, not for leg cramps.
• Read labels carefully. OTC “cramp relief” tablets often list quinine as the active ingredient.
• Avoid high‑quinine tonic waters if you have a history of sensitivity or renal disease.
• Inform healthcare providers of any prior quinine reaction before prescribing other medications.
• Genetic screening for G6PD deficiency in populations where the condition is common (e.g., African, Mediterranean, Southeast Asian ancestry) before using quinine.
• Medication reconciliation at every clinic visit to catch accidental duplicate quinine prescriptions.

Complications

If untreated or inadequately managed, quinine fever can lead to serious, sometimes irreversible complications:

• Cardiac arrhythmias – Torsades de pointes or ventricular fibrillation can be fatal.
• Severe hypotension – May cause shock and multi‑organ failure.
• Permanent auditory damage – Up to 10 % of severe cases develop irreversible hearing loss.
• Acute kidney injury (AKI) – May progress to chronic kidney disease.
• Hemolytic anemia – Particularly in G6PD‑deficient individuals; can require transfusion.
• Thrombocytopenic purpura – Bleeding complications, including intracranial hemorrhage.
• Delayed hypersensitivity reactions – Skin necrosis or Stevens‑Johnson syndrome (rare).

When to Seek Emergency Care

Key Take‑away Points

• Quinine fever is an overdose or hypersensitivity reaction to quinine.
• Early recognition (within hours of ingestion) dramatically improves outcomes.
• Management is supportive; there is no antidote.
• Prevention hinges on avoiding self‑medication and proper medical supervision.

Sources: Mayo Clinic. “Quinine side effects”; CDC. “Malaria treatment guidelines”; NIH National Library of Medicine, MedlinePlus – “Quinine toxicity”; WHO. “Guidelines for the Treatment of Malaria”; Cleveland Clinic. “Drug‑induced fever”; JAMA, “Quinine-induced thrombocytopenia and hemolysis” 2022.

```